Multiple Resistance at No Cost: Rifampicin and Streptomycin a Dangerous Liaison in the Spread of Antibiotic Resistance
Open Access
- 30 June 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Molecular Biology and Evolution
- Vol. 32 (10) , 2675-2680
Abstract
Evidence is mounting that epistasis is widespread among mutations. The cost of carrying two deleterious mutations, or the advantage of acquiring two beneficial alleles, is typically lower that the sum of their individual effects. Much less is known on epistasis between beneficial and deleterious mutations, even though this is key to the amount of genetic hitchhiking that may occur during evolution. This is particularly important in the context of antibiotic resistance: Most resistances are deleterious, but some can be beneficial and remarkably rifampicin resistance can emerge de novo in populations evolving without antibiotics. Here we show pervasive positive pairwise epistasis on Escherichia coli fitness between beneficial mutations, which confer resistance to rifampicin, and deleterious mutations, which confer resistance to streptomycin. We find that 65% of double resistant strains outcompete sensitive bacteria in an environment devoid of antibiotics. Weak beneficial mutations may therefore overcome strong deleterious mutations and can even render double mutants strong competitors.Keywords
This publication has 40 references indexed in Scilit:
- Patterns of Epistasis between Beneficial Mutations in an Antibiotic Resistance GeneMolecular Biology and Evolution, 2013
- Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosisEvolution, Medicine, and Public Health, 2013
- Epistasis between mutations is host-dependent for an RNA virusBiology Letters, 2013
- ANTIBIOTIC RESISTANCE AND STRESS IN THE LIGHT OF FISHER'S MODELEvolution, 2012
- Cost of Antibiotic Resistance and the Geometry of AdaptationMolecular Biology and Evolution, 2011
- The causes of epistasisProceedings Of The Royal Society B-Biological Sciences, 2011
- Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosisClinical Microbiology and Infection, 2011
- The cost of multiple drug resistance in Pseudomonas aeruginosaJournal of Evolutionary Biology, 2009
- Epistasis — the essential role of gene interactions in the structure and evolution of genetic systemsNature Reviews Genetics, 2008
- Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter ProteinsScience, 2006